Immetas Therapeutics announces Series A financing to advance research on inflammation pathways in aging and develop therapeutics for cancer and inflammatory disease
Immetas Therapeutics Announces Series A Financing to Advance Research on Inflammation Pathways in Aging and Develop Therapeutics for Cancer and Inflammatory Disease, EAST HANOVER, N.J.–(BUSINESS WIRE)–Immetas Therapeutics today announced it has raised a Series A financing of $11 million to advance research